We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
Cap. Flow
-$37.3M
Cap. Flow %
-11.13%
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134

Top Buys

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$16M
2
STM icon
STMicroelectronics
STM
+$13.6M
3
APH icon
Amphenol
APH
+$10.9M
4
STX icon
Seagate
STX
+$7.07M
5
F icon
Ford
F
+$6.02M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$18.4M
2
LITE icon
Lumentum
LITE
+$14.5M
3
AXTI icon
AXT Inc
AXTI
+$13.3M
4
TSEM icon
Tower Semiconductor
TSEM
+$11.9M
5
MU icon
Micron Technology
MU
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 38.35%
2 Healthcare 29.66%
3 Financials 6.33%
4 Miscellaneous 6.14%
5 Consumer Discretionary 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRL icon
176
Charles River Laboratories
CRL
$13.8B
$267K 0.08%
1,177
-1,466
-55% -$261K
CLRB icon
177
Cellectar Biosciences
CLRB
$22.4M
$258K 0.08%
+92,983
New +$260K
GLUE icon
178
CALL
Monte Rosa Therapeutics
GLUE
$1.18B
$258K 0.08%
+434
New +$8.2K
TNGX icon
179
Tango Therapeutics
TNGX
$3.8B
$258K 0.08%
8,238
-14,878
-64% -$368K
BNTX icon
180
BioNTech
BNTX
$26.1B
$256K 0.08%
+2,755
New +$259K
DBVT
181
DBV Technologies
DBVT
$847M
$256K 0.08%
15,630
+4,238
+37% +$80K
HUYA
182
Huya Inc
HUYA
$484M
$254K 0.08%
110,327
+88,054
+395% +$250K
CLMT icon
183
Calumet Specialty Products
CLMT
$4.67B
$253K 0.08%
+7,037
New +$237K
IRTC icon
184
iRhythm Holdings
IRTC
$4.06B
$253K 0.08%
+2,129
New +$247K
HRMY icon
185
Harmony Biosciences
HRMY
$2.46B
$249K 0.07%
6,843
-16,705
-71% -$527K
ICLR icon
186
Icon
ICLR
$12.7B
$249K 0.07%
1,431
-1,982
-58% -$252K
PCVX icon
187
CALL
Vaxcyte
PCVX
$9.1B
$249K 0.07%
135
– –
NAMS icon
188
NewAmsterdam Pharma
NAMS
$3.04B
$247K 0.07%
+7,284
New +$240K
RCL icon
189
Royal Caribbean
RCL
$70.9B
$247K 0.07%
+777
New +$217K
BMY icon
190
CALL
Bristol-Myers Squibb
BMY
$136B
$244K 0.07%
+1,535
New +$88.1K
RRX icon
191
Regal Rexnord
RRX
$10.8B
$243K 0.07%
+1,019
New +$213K
PRKS icon
192
United Parks & Resorts
PRKS
$1.83B
$237K 0.07%
+4,965
New +$193K
MDT icon
193
Medtronic
MDT
$121B
$236K 0.07%
3,012
-234
-7% -$18.9K
CRBP icon
194
CALL
Corbus Pharmaceuticals
CRBP
$214M
$235K 0.07%
1,615
+1,323
+453% +$12.5K
ALH
195
Alliance Laundry Holdings
ALH
$4.52B
$232K 0.07%
+8,759
New +$219K
RNAC icon
196
Cartesian Therapeutics
RNAC
$280M
$231K 0.07%
+22,191
New +$164K
FHTX icon
197
Foghorn Therapeutics
FHTX
$292M
$229K 0.07%
46,872
+228
+0.5% +$1.01K
RIGL icon
198
Rigel Pharmaceuticals
RIGL
$909M
$228K 0.07%
+5,821
New +$180K
ARQT icon
199
Arcutis Biotherapeutics
ARQT
$3B
$227K 0.07%
+8,657
New +$202K
H icon
200
Hyatt Hotels
H
$15.6B
$223K 0.07%
+1,152
New +$202K
6 7
8
9 10

Similar funds

JWM
Jessup Wealth Management Dayton, Ohio $335M AUM 56.2% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $335M AUM 97.32% 1-Year Est. Return
TFA
TPG Financial Advisors Portland, Oregon $335M AUM 14.14% 1-Year Est. Return
SIM
Seaview Investment Managers Miami, Florida $335M AUM 47.2% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $336M AUM 20.38% 1-Year Est. Return
SS
Spinecap SAS Paris, France $335M AUM 16.94% 1-Year Est. Return
BIA
BHK Investment Advisors Birmingham, Alabama $335M AUM 20.89% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

Persistent Asset Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.

  • Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
  • Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
  • Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
  • Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
  • Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
  • Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
  • Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.